Formosa Laboratories Stock

Formosa Laboratories EBIT

The EBIT of Formosa Laboratories (4746.TW) as of Aug 18, 2026 is 803.18 M TWD. In the previous year, EBIT was 750.04 M TWD — a change of 7.08% (higher).

EBIT

803.18 MTWD

YoY

7.08%

Last updated:

In 2026, Formosa Laboratories's EBIT was 803.18 M TWD, a 7.08% increase from the 750.04 M TWD EBIT recorded in the previous year.

The Formosa Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B TWD)
Date
EBIT (B TWD)
Jan 1, 2019
-0.01 base
Jan 1, 2020
0.42 base
Jan 1, 2021
1.10 base
Jan 1, 2022
0.38 base
Jan 1, 2023
0.67 base
Jan 1, 2024
0.75 base
Jan 1, 2025
0.80 base
Jan 1, 2026 (e)
0.79 base
YEAREBIT (B TWD)
2026 est 0.79
2025 0.80
2024 0.75
2023 0.67
2022 0.38
2021 1.10
2020 0.42
2019 -0.01
2018 0.06
2017 0.38
2016 0.66
2015 0.33
2014 0.27
2013 -0.08
2012 0.04
2011 0.24
2010 0.32
2009 0.25
2008 0.22
2007 0.15
2006 0.13
Access this data via the Eulerpool API

Formosa Laboratories Revenue

Formosa Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
2.76 B TWD
-11.50 M TWD
-41.06 M TWD
Jan 1, 2020
3.08 B TWD
420.42 M TWD
400.03 M TWD
Jan 1, 2021
3.14 B TWD
1.10 B TWD
1.25 B TWD
Jan 1, 2022
3.77 B TWD
380.85 M TWD
216.81 M TWD
Jan 1, 2023
4.36 B TWD
674.98 M TWD
126.24 M TWD
Jan 1, 2024
4.73 B TWD
750.04 M TWD
157.27 M TWD
Jan 1, 2025
4.85 B TWD
803.18 M TWD
441.11 M TWD
Jan 1, 2026 (e)
4.86 B TWD
792.48 M TWD
233.53 M TWD

Formosa Laboratories Margins

Formosa Laboratories stock margins

The Formosa Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Formosa Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Formosa Laboratories.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
29.91 %
-0.42 %
-1.49 %
Jan 1, 2020
30.73 %
13.67 %
13.01 %
Jan 1, 2021
30.91 %
35.06 %
39.75 %
Jan 1, 2022
36.92 %
10.11 %
5.76 %
Jan 1, 2023
44.11 %
15.48 %
2.90 %
Jan 1, 2024
43.30 %
15.85 %
3.32 %
Jan 1, 2025
41.89 %
16.56 %
9.09 %
Jan 1, 2026 (e)
41.89 %
16.32 %
4.81 %

Formosa Laboratories Stock analysis

What does Formosa Laboratories do? Formosa Laboratories, Inc. is a renowned company in the field of research and development, pharmaceuticals, and diagnostics, operating in the industry for over 30 years. Founded in 1989, the company has become one of the leading providers of innovative solutions and products that allow its customers to improve their healthcare and enhance their quality of life. The business model of Formosa Laboratories is focused on meeting the high demands of its customers. The company works closely with medical professionals, scientists, and researchers to develop products that meet the needs of patients. With an experienced and diverse team of experts in areas such as research and development, quality control, production, marketing, and sales, Formosa Laboratories is able to offer fast and effective solutions for all customer requirements. The company has divided its various business areas into different divisions, each specialized in different areas of medicine and diagnostics. The three main business divisions are research and development, pharmaceuticals, and diagnostics. In the field of research and development, the company offers services such as preclinical research, biologics research, and development strategies. The company is dedicated to researching new control procedures and technologies to ensure the effectiveness of its solutions. Formosa Laboratories takes pride in its innovative research and development team, which stays up to date with the latest technology and continuously develops new products to meet the needs of its customers. In the pharmaceutical field, the company offers a wide range of prescription and non-prescription medications prescribed by doctors around the world. Formosa Laboratories relies on close collaboration with its customers to ensure that each patient receives the best possible medical care. The company is committed to manufacturing high-quality and safe medications. In the field of diagnostics, the company offers a variety of diagnostic tests and kits that allow for accurate and fast diagnosis of various diseases and conditions. With advanced technology and precise test results, Formosa Laboratories helps doctors and medical professionals make quick and accurate diagnoses to start treatment as soon as possible. Over the years, Formosa Laboratories has developed numerous products that have improved people's lives and fought against diseases. Some of the company's well-known products include: - Influenza Rapid Tests: A fast and accurate test for diagnosing the flu. - Pregnancy Test Kits: A traditional pregnancy test that is able to confirm or exclude pregnancy in a woman. - Needle-free Syringes: An innovation that allows for medication injection without a needle. In conclusion, Formosa Laboratories Inc is a significant company in the medical and diagnostics industry, dedicated to manufacturing high-quality and safe products. With its experienced and qualified team, the company is able to offer fast and effective solutions tailored to the individual needs of its customers. Formosa Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Formosa Laboratories's EBIT

Formosa Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Formosa Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Formosa Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Formosa Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Formosa Laboratories stock

EBIT of Formosa Laboratories is 803.18 M TWD in 2026.

EBIT of Formosa Laboratories changed from 750.04 M TWD to 803.18 M TWD, representing a 7.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Formosa Laboratories since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Formosa Laboratories historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Formosa Laboratories

All Key Metrics — Formosa Laboratories